Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; A randomised clinical trial

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  IJff, Marjoliek A ^a,b   Huijbregts, Klaas M L ^a,b   Van Marwijk, Harm W J ^b,c   Beekman, Aartjan T F ^a,b,c   Hakkaart Van Roijen, Leona ^d   Rutten, Frans F ^d   Unützer, Jürgen ^e   Van Der Feltz Cornelis, Christina M ^a,b,c  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; FOLLOW UP; GENERAL PRACTICE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INTERVIEW; MAJOR DEPRESSION; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROBLEM SOLVING; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TREATMENT OUTCOME; ALGORITHM; COST BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; ECONOMICS; MULTICENTER STUDY; PRIMARY HEALTH CARE; PROCEDURES;

ALGORITHMS; ANTIDEPRESSIVE AGENTS; COMORBIDITY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; HUMANS; NETHERLANDS; PRIMARY HEALTH CARE; PROBLEM SOLVING;

EID: 33847699774     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-34     Document Type: Article

References (93)

1. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 1498 1504 10.1016/S0140-6736(96)07492-2 9167458
2. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). RV Bijl A Ravelli G van Zessen, Soc Psychiatry Psychiatr Epidemiol 1998 33 587 595 10.1007/s001270050098 9857791
3. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - findings from the Netherlands Mental Health Survey and Incidence Study. R De Graaf RV Bijl J Spijker ATF Beekman WA Vollebergh, Soc Psychiatry Psychiatr Epidemiol 2003 38 1 11 10.1007/s00127-003- 0597-4 12563553
4. [Undertreatment of depression; causes and recommendations. In Dutch]. J Ormel M Bartel WA Nolen, Ned Tijdschr Geneeskd 2003 147 1005 1009 12811970
5. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. PA Nutting K Rost J Smith JJ Werner C Elliot, Arch Fam Med 2000 9 1059 1064 10.1001/archfami.9.10.1059 11115208
6. Consultation length in general practice: cross sectional study in six European countries. M Deveugele A Derese A Brink-Muinen J Bensing J de Maeseneer, BMJ 2002 325 472 12202329 10.1136/bmj.325.7362.472
7. An international study of the relation between somatic symptoms and depression. GE Simon M Von Korff M Piccinelli C Fullerton J Ormel, N Engl J Med 1999 341 1329 1335 10.1056/NEJM199910283411801 10536124
8. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. MW De Waal IA Arnold JA Eekhof AM van Hemert, Br J Psychiatry 2004 184 470 476 10.1192/bjp.184.6.470 15172939
9. Pain predicts longer time to remission during treatment of recurrent depression. JF Karp J Scott P Houck CF Reynolds III DJ Kupfer E Frank, J Clin Psychiatry 2005 66 591 597 15889945
10. Relationship of depression to medical illness. A critical review. RG Kathol F Petty, J Affect Disord 1981 3 111 121 10.1016/0165-0327(81)90036-7 6454705
11. Comorbidity in primary care: presentation and consequences. HU Wittchen R Lieb U Wunderlich P Schuster, J Clin Psychiatry 1999 60 Suppl 7 29 36 10326872
12. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. R Mergl I Seidscheck AK Allgaier HJ Moller U Hegerl V Henkel, Depress Anxiety 2006
13. Comorbidity associated with neurologic and psychiatric diseases: A general practice-based controlled study. J Nuyen FG Schellevis WA Satariano PM Spreeuwenberg MD Birkner GAM van den Bos PP Groenewegen, J of Clin Epidemiol
14. Depression in Adults with Diabetes. PJ Lustman LS Griffith RE Clouse, Semin Clin Neuropsychiatry 1997 2 15 23 10320439
15. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. WJ Katon, Biol Psychiatry 2003 54 216 226 10.1016/S0006-3223(03)00273-7 12893098
16. Diabetes, depression, and quality of life: a population study. RD Goldney PJ Phillips LJ Fisher DH Wilson, Diabetes Care 2004 27 1066 1070 10.2337/diacare.27.5.1066 15111522
17. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. JA Cully DP Graham MA Stanley CJ Ferguson A Sharafkhaneh J Souchek ME Kunik, Psychosomatics 2006 47 312 319 10.1176/appi.psy.47.4.312 16844889
18. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. A Gehi D Haas S Pipkin MA Whooley, Arch Intern Med 2005 165 2508 2513 10.1001/archinte.165.21.2508 16314548
19. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. PS Ciechanowski WJ Katon JE Russo, Arch Intern Med 2000 160 3278 3285 10.1001/archinte.160.21.3278 11088090
20. Increased medical costs of a population-based sample of depressed elderly patients. WJ Katon EH Lin JE Russo J Unutzer, Arch Gen Psychiatry 2003 60 897 903 10.1001/archpsyc.60.9.897 12963671
21. Helping patients improve their health-related behaviors: what system changes do we need? T Bodenheimer, Dis Manag 2005 8 319 330 10.1089/dis.2005.8. 319 16212517
22. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. HC Schulberg WJ Katon GE Simon AJ Rush, Arch Gen Psychiatry 1998 55 1121 1127 10.1001/archpsyc.55.12.1121 9862556
23. Effectiveness of disease management programmes for recognition, diagnosis and treatment of depression in primary care. D Bijl HWJ van Marwijk M de Haan W van Tilburg ATF Beekman, Eur J Gen Pract 2004 10 6 12 15060475
24. Randomised Controlled Trial of a Collaborative Care Model with Psychiatric Consultation for Persistent Medically Unexplained Symptoms in General Practice. CM Van der Feltz-Cornelis P van Oppen H Adèr R van Dyck, Psychother Psychosom 2006 75 282 289 10.1159/000093949 16899964
25. Treating depression in primary care practice: applications of research findings. HC Schulberg, J Fam Pract 2001 50 535 537 11401741
26. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. WJ Katon M Von Korff EH Lin GE Simon EA Walker J Unutzer T Bush J Russo E Ludman, Arch Gen Psychiatry 1999 56 1109 1115 10.1001/archpsyc.56.12.1109 10591288
27. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. J Unutzer WJ Katon CM Callahan JW Williams Jr EM Hunkeler L Harpole M Hoffing RD Della Penna P Hitchcock Noël EHB Lin PA Areán MT Hegel L Tang TR Belin SM Oishi CA Langston, JAMA 2002 288 2836 2845 10.1001/jama.288.22.2836 12472325
28. Long-term effects of a collaborative care intervention in persistently depressed primary care patients. WJ Katon JE Russo M Von Korff EH Lin GE Simon T Bush E Ludman E Walker, J Gen Intern Med 2002 17 741 748 12390549 10.1046/j.1525-1497.2002.11051.x
29. [Collaborative care for physically unexplained symptoms in primary care. Results and profits for general practitioners. In Dutch]. CM Van der Feltz-Cornelis P van Oppen H Adèr R van Dyck, Huisarts & Wetenschap 2006 49 342 347
30. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. S Gilbody P Bower J Fletcher D Richards AJ Sutton, Arch Intern Med 2006 166 2314 2321 10.1001/archinte.166.21.2314 17130383
31. Collaborative care for depression in primary care: Making sense of a complex intervention: systematic review and meta-regression. P Bower S Gilbody D Richards J Fletcher A Sutton, Br J Psychiatry 2006 189 484 493 10.1192/bjp.bp.106.023655 17139031
32. Improving primary care for depression in late life: the design of a multicenter randomized trial. J Unutzer WJ Katon JW Williams Jr CM Callahan L Harpole EM Hunkeler M Hoffing PA Areán MT Hegel M Schoenbaum SM Oishi CA Langston, Med Care 2001 39 785 799 10.1097/00005650-200108000-00005 11468498
33. Case management to improve major depression in primary health care: a systematic review. J Gensichen M Beyer C Muth FM Gerlach M Von Korff J Ormel, Psychol Med 2006 36 7 14 10.1017/S0033291705005568 16356292
34. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. LM Mynors-Wallis DH Gath A Day F Baker, BMJ 2000 320 26 30 10617523 10.1136/bmj.320.7226.26
35. A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. LM Mynors-Wallis I Davies A Gray F Barbour DH Gath, Br J Psychiatry 1997 170 113 119 9093498
36. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. LM Mynors-Wallis DH Gath AR Lloyd-Thomas D Tomlinson, BMJ 1995 310 441 445 7873952
37. CBO, Trimbos-instituut, Multidisciplinairy Guideline Depressive disorder [Multidisciplinaire Richtlijn Depressie. In Dutch] Utrecht: Trimbos-insituut 2005
38. P Cuijpers, [In de put, uit de put. Zelf depressiviteit overwinnen. In Dutch] Baarn: HB Uitgevers 2003
39. P Cuijpers H Buijssen, [Ik zie het weer zitten. Omgaan met depressiviteit/Control your depression. In Dutch] Utrecht: Teleac/NOT 1997
40. Minimal-contact psychotherapy for sub-threshold depression in primary care. Randomised trial. GR Willemse F Smit P Cuijpers BG Tiemens, Br J Psychiatry 2004 185 416 421 10.1192/bjp.185.5.416 15516551
41. The cost-effectiveness of Collaborative Care for Depressive Disorder in the Occupational Health Setting; study protocol of a randomised controlled trial. M Vlasveld ATF Beekman L Hakkaart-van Roijen R Hoedeman HWJ van Marwijk CM van der Feltz-Cornelis, BMC, article under construction
42. Problem-solving treatment in general psychiatric practice. LM Mynors-Wallis, Adv Psych Treatment 2001 7 417 425 10.1192/apt.7.6.417
43. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study. M Adli A Berghofer M Linden H Helmchen B Muller-Oerlinghausen A Mackert T Stamm M Bauer, J Clin Psychiatry 2002 63 782 790 12363118
44. A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study. G Bondolfi JM Aubry J Golaz M Gex-Fabry N Gervasoni G Bertschy, Swiss Med Wkly 2006 136 78 85 16633950
45. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. MH Trivedi AJ Rush ML Crismon TM Kashner MG Toprac TJ Carmody T Key MM Biggs K Shores-Wilson B Witte T Suppes AL Miller KZ Altshuler SP Shon, Arch Gen Psychiatry 2004 61 669 680 10.1001/archpsyc.61.7.669 15237079
46. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. B Arroll S Macgillivray S Ogston I Reid F Sullivan B Williams I Crombie, Ann Fam Med 2005 3 449 456 16189062 10.1370/afm.349
47. AR Feinstein, Clinical epidemiology: the architecture of clinical research Philadelphia: WB Saunders First 1985
48. The PHQ-9: validity of a brief depression severity measure. K Kroenke RL Spitzer JB Williams, J Gen Intern Med 2001 16 606 613 11556941 10.1046/j.1525-1497.2001.016009606.x
49. [The MINI-International neuropsychiatric interview: a short, structured, diagnostic interview for DSM-IV and ICD-10 psychiatric disorders. In Dutch]. IM Van Vliet H Leroy HJM van Megen, Leiden: LUMC 2000
50. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller T Hergueta R Baker GC Dunbar, J Clin Psychiatry 1998 59 Suppl 20 22 33 9881538
51. [Less is more. Stepped care in mental health care. In Dutch]. JAC Meeuwissen MCH Donker, Maandblad Geestelijke Volksgezondheid 2004 59 904 915
52. Clinicians' adherence to an algorithm for pharmacotherapy of depression in the Texas public mental health sector. TL Bettinger ML Crismon MH Trivedi B Grannemann SP Shon, Psychiatr Serv 2004 55 703 705 10.1176/appi.ps.55.6.703 15175470
53. Psychiatric consultation for patients with somatoform disorder in general practice. CM Van der Feltz-Cornelis, PhD-thesis VU Amsterdam 2002
54. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (4th ed. TR) Washington DC 2000
55. The treatment of insomnia through mass media, the results of a televised behavioral training programme. A Oosterhuis EC Klip, Soc Sci Med 1997 45 1223 1229 10.1016/S0277-9536(97)00041-5 9381235
56. Effectiveness of complementary and self-help treatments for depression. AF Jorm H Christensen KM Griffiths B Rodgers, Med J Aust 2002 176 Suppl S84 S96 12065003
57. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. J Sontrop MK Campbell, Prev Med 2006 42 4 13 10.1016/j.ypmed.2005.11.005 16337677
58. [Runningtherapy in the treatment of Depressive disorder. In Dutch]. RJ Bosscher, PhD-thesis VU Amsterdam 1991
59. Cost-effectiveness of treatment of depression in primary care. JE Bosmans, PhD-thesis VU Amsterdam 2006
60. Monitoring depression treatment outcomes with the patient health questionnaire-9. B Lowe J Unutzer CM Callahan AJ Perkins K Kroenke, Med Care 2004 42 1194 1201 10.1097/00005650-200412000-00006 15550799
61. L Hakkaart-van Roijen, [Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness. In Dutch] Rotterdam: Institute for Medical Technology Assessment 2002
62. Cost-utility of brief psychological treatment for depression and anxiety. L Hakkaart-van Roijen A Straten van MJ Al F Rutten M Donker, Br J Psychiatry 2006 323 329 10.1192/bjp.188.4.323 16582058
63. Euroqol group, Eq-5D user guide Rotterdam: Sanders instituut, eur 1995
64. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. JE Ware Jr CD Sherbourne, Med Care 1992 30 473 483 10.1097/00005650-199206000-00002 1593914
65. AM Hemert, [Bodily Complaints Questionnaire. In Dutch] Leiden: Leids Universitair Medisch Centrum 2003
66. A new approach to the assessment of the treatment effects of somatoform disorders. W Rief W Hiller, Psychosomatics 2003 44 492 498 10.1176/appi.psy.44. 6.492 14597684
67. A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patients. AE Speckens P Spinhoven PP Sloekers JH Bolk AM van Hemert, J Psychosom Res 1996 40 95 104 10.1016/0022-3999(95)00561-7 8730649
68. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. EM Smets B Garssen B Bonke JC de Haes, J Psychosom Res 1995 39 315 325 10.1016/0022-3999(94)00125-O 7636775
69. Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. RA Schneider, Cancer Nurs 1998 21 370 373 10.1097/00002820-199810000-00009 9775488
70. WHO, Disability Assessment Schedule II (WHO-DAS-II), brief version pilot, interviewer's manual Geneva: WHO 1998
71. The Inventory of Depressive Symptomatology (IDS): psychometric properties. AJ Rush CM Gullion MR Basco RB Jarrett MH Trivedi, Psychol Med 1996 26 477 486 8733206
72. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. MH Trivedi AJ Rush HM Ibrahim TJ Carmody MM Biggs T Suppes ML Crismon K Shores-Wilson MG Toprac EB Dennehy B Witte TM Kashner, Psychol Med 2004 34 73 82 10.1017/S0033291703001107 14971628
73. A patient-doctor relationship questionnaire (PDRQ-9) in primary care: development and psychometric evaluation. CM Van der Feltz-Cornelis P van Oppen HWJ van Marwijk E de Beurs R van Dyck, Gen Hosp Psychiatry 2004 26 115 120 10.1016/j.genhosppsych.2003.08.010 15038928
74. General practitioners and depression first use of the depression attitude questionnaire. N Botega R Blizard DG Wilkinson A Mann, International Journal of Methods for Psychiatric Research 1992 4 169 180
75. The Social Readjustment Rating Scale. TH Holmes RH Rahe, J Psychosom Res 1967 11 213 218 10.1016/0022-3999(67)90010-4 6059863
76. HA Hoekstra F de Fruyt, [NEO-PI-R and NEO-FFI: Big Five Personality-questionnaires: Manual. In Dutch] Lisse: Swets & Zeitlinger 1996
77. Neuroticism: a vulnerability marker for depression evidence from a family study. C Duggan P Sham A Lee C Minne R Murray, J Affect Disord 1995 35 139 143 10.1016/0165-0327(95)00062-3 8749842
78. JB Oostenbrink CAM Bouwmans MA Koopmanschap FF Rutten, [Handleiding voor kostenonderzoek, methoden en standaardkostprijzen voor economische evaluaties in de gezondheidszorg. In Dutch] College voor zorgverzekeringen 2004
79. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. L Van Roijen ML Essink-Bot MA Koopmanschap G Bonsel FF Rutten, Int J Technol Assess Health Care 1996 12 405 415 8840661
80. [Costeffectiveness of psychotherapy: A feasiblity study. In Dutch]. QD Van Dam A Spijker LR Arends, J of Pychotherapy 1998 24 5 22
81. A practical guide for calculating indirect costs of disease. MA Koopmanschap FF Rutten, Pharmacoeconomics 1996 10 460 466 10172868
82. The friction cost method for measuring indirect costs of disease. MA Koopmanschap FF Rutten BM van Ineveld L van Roijen, J Health Econ 1995 14 171 189 10.1016/0167-6296(94)00044-5 10154656
83. Multiple imputation after 18+ years. DB Rubin, J Am Stat Assoc 1996 91 473 489 10.2307/2291635
84. Costs, effects and C/E-ratios alongside a clinical trial. BA Van Hout MJ Al GS Gordon FF Rutten, Health Econ 1994 3 309 319 7827647
85. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. M Adli M Bauer AJ Rush, Biol Psychiatry 2006 59 1029 1038 10.1016/j.biopsych.2006.05.010 16769294
86. Effectiveness of disease management programs in depression: a systematic review. E Badamgarav SR Weingarten JM Henning K Knight V Hasselblad A Gano Jr JJ Ofman, Am J Psychiatry 2003 160 2080 2090 10.1176/appi.ajp.160.12.2080 14638573
87. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. A Neumeyer-Gromen T Lampert K Stark G Kallischnigg, Med Care 2004 42 1211 1221 10.1097/00005650-200412000- 00008 15550801
88. Disease management programs in the USA and Europe are comparable (yet?) different. G Schrijvers, Int J Integr Care 2006 6 e13 17006551
89. From establishing an evidence-based practice to implementation in real-world settings: IMPACT as a case study. J Unutzer D Powers WJ Katon CA Langston, Psychiatr Clin North Am 2005 28 1079 1092 10.1016/j.psc.2005.09.001 16325741
90. Cognitive therapy vs medications in the treatment of moderate to severe depression. RJ DeRubeis SD Hollon JD Amsterdam RC Shelton PR Young RM Salomon JP O'Reardon ML Lovett MM Gladis LL Brown R Gallop, Arch Gen Psychiatry 2005 62 409 416 10.1001/archpsyc.62.4.409 15809408
91. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? SD Hollon RB Jarrett AA Nierenberg ME Thase MH Trivedi AJ Rush, J Clin Psychiatry 2005 66 455 468 15816788
92. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. SD Hollon RJ DeRubeis RC Shelton JD Amsterdam RM Salomon JP O'Reardon ML Lovett PR Young KL Haman BB Freeman S Gallop, Arch Gen Psychiatry 2005 62 417 422 10.1001/archpsyc.62.4.417 15809409
93. Combined pharmacotherapy and psychological treatment for depression: a systematic review. S Pampallona P Bollini G Tibaldi B Kupelnick C Munizza, Arch Gen Psychiatry 2004 61 714 719 10.1001/archpsyc.61.7.714 15237083